Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2019 Aug 1;81(4):e104–e108. doi: 10.1097/QAI.0000000000002054

Figure 1:

Figure 1:

Pre-Exposure Care Cascade for Individuals Starting PrEP from 1/1/2015 through 11/30/2017 and followed through 9/30/2017 for Retention in Care Through the First Three Visits and Re-Engagement at Any Time. *”First follow-up visit” was defined as having a visit between day 14 and day 60 or documentation of enough prescription refills to last within one week of the second follow-up visit.

**”Second follow-up visit,” was defined as having a visit between day 60 and day 165, and no more than 120 days from prior visit, or documentation of having prescription refills to last within one week of the visit.

***”Third follow-up visit,” was defined as completing second follow-up visit and having a visit between day 135 and day 285, no more than 120 days from prior visit, or documentation of having prescription refills to last within one week of the visit.